![]() |
市場調查報告書
商品編碼
1813437
2032 年植物育種和 CRISPR 植物市場預測:按性狀、作物類型、育種方法、技術、最終用戶和地區進行的全球分析Plant Breeding and CRISPR Plants Market Forecasts to 2032 - Global Analysis By Trait, Crop Type, Breeding Method, Technology, End User and By Geography |
根據 Stratistics MRC 的數據,全球植物育種和 CRISPR 植物市場預計在 2025 年達到 187.6 億美元,預計到 2032 年將達到 580.1 億美元,預測期內的複合年成長率為 17.5%。
植物育種和 CRISPR 技術致力於提高作物的產量、韌性和對環境條件的適應性。傳統育種依賴選擇性育種,而 CRISPR-Cas9 透過修改選定的 DNA 區域提供精準的基因編輯。結合這些方法可以加快作物生長,減少化學投入,並增強糧食安全。這項技術創新促進了永續農業的發展,有助於滿足日益成長的營養需求,同時應對病蟲害和氣候變遷等挑戰。
美國太空總署在《自然食品》雜誌上發表的一項研究發現,高溫室氣體排放可能導致玉米產量到 2030 年減少 24%。
全球對產量、營養作物的需求不斷成長
由於人口成長,全球糧食系統面臨巨大壓力,對高產量且營養豐富的作物的需求激增。農業相關人員擴大轉向能夠抵禦環境壓力和病蟲害的抗逆性作物品種。 CRISPR 等尖端育種工具正在加速此類性狀的開發,從而實現更精準、更有效率的作物改良。這些技術縮短了育種時間,提高了遺傳準確性,使其具有大規模推廣的吸引力。消費者對更健康食品選擇的興趣也推動了對營養作物品種的需求。隨著糧食安全成為重中之重,全球對下一代植物遺傳學的投資正日益成長。
小農戶的認知和採用程度有限
許多農民缺乏可靠的資訊、培訓和推廣服務,無法理解先進的基因技術。低數位素養、語言障礙以及對生物技術創新的懷疑加劇了這種知識差距。此外,基於CRISPR的解決方案被認為複雜且成本高昂,阻礙了其推廣,尤其是在以傳統農業為主的地區。如果沒有針對性的推廣、全面的政策框架和基於社區的示範計劃,CRISPR在提高作物抗逆性和生產力方面的變革潛力仍未得到充分利用。
對生物強化作物的需求不斷增加
生物強化作物作為應對微量營養素缺乏和改善公眾健康的策略解決方案,正受到全球關注。 CRISPR技術能夠精準強化主食的營養成分,例如提高鐵、鋅和維生素的含量。這些創新技術正被納入糧食援助計畫、學校午餐和以健康為重點的農業政策中。代謝工程的進步使得在不影響產量或口感的情況下,更輕鬆地實現作物增產。隨著人們對「隱性飢餓」認知的不斷提高,生物強化正成為永續營養策略的重要支柱。生物技術創新與健康成果的結合,正在為該產業創造新的成長機會。
全球法規嚴格,核准延遲
基因改造作物的監管格局仍然碎片化,為開發者帶來了不確定性,並減緩了市場發展。核准流程通常冗長且不一致,尤其是在跨國領域。圍繞基因技術的社會擔憂和倫理爭議持續影響政策決策。在許多地區,缺乏統一的標準使商業化和貿易變得複雜。這些監管瓶頸增加了成本,並減緩了創新,尤其對規模較小的生物技術公司而言。如果沒有更清晰、更有效率的核准途徑,全球採用的步伐可能會受到嚴重阻礙。
COVID-19的影響
疫情擾亂了農業研究和供應鏈,推遲了基於CRISPR技術的作物的測試和監管審查。旅行限制和有限的線下培訓限制了農民接觸新技術的機會,尤其是在發展中地區。同時,這場危機凸顯了對能夠在逆境中穩定糧食系統的抗逆作物的需求。遠距協作工具和數位農學平台有助於維持研究和推廣工作。隨著糧食不安全狀況的蔓延,對營養豐富、易儲存作物的需求不斷增加。
預計在預測期內,抗除草劑部分將實現最大程度的成長。
由於在商業性農業中廣泛使用,抗除草劑品種預計將在預測期內佔據最大的市場佔有率。這些品種簡化了雜草控制,減少了勞動力需求,並提高了整體生產力。 CRISPR 提高了抗除草劑性狀的精準度,最大限度地減少了意外影響和環境風險。農民擴大種植這些作物以簡化操作並提高盈利。多重抗性狀以及與智慧噴灑系統的整合等創新技術正在獲得越來越多的關注。除草劑抗性的經濟和營運效益使其成為現代作物開發的關鍵性狀。
預計生物技術公司部門在預測期內將以最高的複合年成長率成長。
生物技術公司預計將在預測期內實現最高成長率,這得益於其快速創新和部署先進基因編輯解決方案的能力。這些公司在利用基因組圖譜和合成生物學開發複雜性狀方面處於領先地位。與學術機構和農產品領導者的合作正在加速產品和市場的發展。強勁的投資流和良好的智慧財產權環境正在支持它們的擴張。生技公司也主導與監管機構溝通,並向大眾宣傳CRISPR的安全性。它們的敏捷性和技術專長將使其在競爭激烈的環境中保持成長。
由於糧食需求不斷成長以及政府對農業生物技術的支持,預計亞太地區將在預測期內佔據最大的市場佔有率。中國和印度等主要經濟體正大力投資CRISPR研究和作物現代化。該地區多樣化的農業需求推動了基因編輯品種在穀物、蔬菜和豆類中的應用。官民合作關係和政策改革正在加速應用。育種計畫的在地化以及使用母語與農民溝通正在提高農業參與度。
由於強大的科學研究生態系統和先進的監管政策,北美預計將在預測期內實現最高的複合年成長率。該地區擁有領先的生物技術公司和大學,正在推動農業創新。在數位化農業平台的支持下,CRISPR 在作物和特種作物中的應用正在不斷成長。人工智慧賦能的性狀選擇和精準表現型分析等趨勢正在重塑作物發展。與食品公司和運動營養品牌的合作正在推動對改良品種的需求。
According to Stratistics MRC, the Global Plant Breeding and CRISPR Plants Market is accounted for $18.76 billion in 2025 and is expected to reach $58.01 billion by 2032 growing at a CAGR of 17.5% during the forecast period. Plant breeding and CRISPR technology focus on enhancing crops with better yield, resilience, and adaptability to environmental conditions. Conventional breeding depends on selective crossing, whereas CRISPR-Cas9 offers accurate genetic editing by modifying chosen DNA regions. By combining these approaches, crop development becomes faster, reduces chemical inputs, and strengthens food security. This innovation fosters sustainable agriculture, helping meet growing nutritional needs while tackling challenges of pests, diseases, and climate change.
According to a NASA study published in Nature Food, maize production could decline by 24% as early as 2030 under high greenhouse gas emissions.
Rising global demand for high-yield and nutritious crops
Global food systems are under mounting pressure as populations grow, prompting a surge in demand for crops that deliver both high productivity and improved nutrition. Agricultural stakeholders are increasingly turning to resilient crop varieties that can withstand environmental stressors and pests. Advanced breeding tools like CRISPR are accelerating the development of such traits, enabling more precise and efficient crop improvement. These technologies shorten breeding timelines and enhance genetic accuracy, making them attractive for large-scale deployment. Consumer interest in healthier food options is also fueling momentum for nutrient-rich crop varieties. As food security becomes a top priority, investment in next-gen plant genetics is gaining traction worldwide.
Limited awareness and adoption among small-scale farmers
Many farmers lack access to reliable information, training, and extension services that could demystify advanced genetic technologies. This knowledge gap is compounded by low digital literacy, language barriers, and scepticism toward biotech innovations. Additionally, the perceived complexity and cost of CRISPR-based solutions deter uptake, especially in regions where traditional farming practices dominate. Without targeted outreach, inclusive policy frameworks, and localized demonstration projects, the transformative potential of CRISPR in enhancing crop resilience and productivity remains underutilized.
Rising demand for biofortified crops
Biofortified crops are gaining global attention as a strategic solution to combat micronutrient deficiencies and improve public health. CRISPR enables precise enhancement of nutritional content in staple foods, such as boosting iron, zinc, and vitamin levels. These innovations are being integrated into food aid programs, school meals, and health-focused agricultural policies. Advances in metabolic engineering are making it easier to enrich crops without compromising yield or taste. As awareness of "hidden hunger" grows, biofortification is emerging as a key pillar of sustainable nutrition strategies. The alignment of biotech innovation with health outcomes is opening new growth opportunities in this space.
Stringent global regulations and approval delays
The regulatory landscape for gene-edited crops remains fragmented, creating uncertainty for developers and slowing market entry. Approval processes are often lengthy and inconsistent, especially across international borders. Public concerns and ethical debates around genetic technologies continue to influence policy decisions. In many regions, the absence of harmonized standards complicates commercialization and trade. These regulatory bottlenecks increase costs and delay innovation, particularly for smaller biotech firms. Without clearer and more efficient approval pathways, the pace of global adoption may be significantly hindered.
Covid-19 Impact
The pandemic disrupted agricultural research and supply chains, delaying trials and regulatory reviews for CRISPR-based crops. Restrictions on movement and in-person training limited farmers' exposure to new technologies, especially in developing regions. At the same time, the crisis underscored the need for resilient crops that can stabilize food systems under stress. Remote collaboration tools and digital agronomy platforms helped sustain research and outreach efforts. Demand for nutrient-dense, shelf-stable crops rose as food insecurity became more widespread.
The herbicide tolerance segment is expected to be the largest during the forecast period
The herbicide tolerance segment is expected to account for the largest market share during the forecast period, due to their widespread use in commercial agriculture. These varieties simplify weed control, reduce labor demands, and enhance overall productivity. CRISPR is improving the precision of herbicide resistance traits, minimizing unintended effects and environmental risks. Farmers are increasingly adopting these crops to streamline operations and boost profitability. Innovations such as multi-resistance traits and integration with smart spraying systems are gaining traction. The economic and operational advantages of herbicide tolerance make it a leading trait in modern crop development.
The biotech firms segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the biotech firms segment is predicted to witness the highest growth rate, driven by their ability to rapidly innovate and deploy advanced gene-editing solutions. These firms are at the forefront of developing complex traits through genome mapping and synthetic biology. Collaborations with academic institutions and agribusiness leaders are accelerating product development and market access. Strong investment flows and favourable intellectual property environments are supporting expansion. Biotech players are also leading efforts to engage regulators and educate the public on CRISPR safety. Their agility and technical expertise position them for sustained growth in a competitive landscape.
During the forecast period, the Asia Pacific region is expected to hold the largest market share fuelled by rising food demand and government support for agricultural biotechnology. Major economies like China and India are investing heavily in CRISPR research and crop modernization. The region's diverse agricultural needs are driving adoption of gene-edited varieties across grains, vegetables, and pulses. Public-private partnerships and policy reforms are helping accelerate deployment. Localization of breeding programs and farmer outreach in native languages are improving engagement.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its strong research ecosystem and progressive regulatory stance. The region is home to leading biotech firms and universities driving agricultural innovation. CRISPR adoption is expanding across both commodity and specialty crops, supported by digital farming platforms. Trends like AI-powered trait selection and precision phenotyping are reshaping crop development. Partnerships with food companies and sports nutrition brands are boosting demand for enhanced varieties.
Key players in the market
Some of the key players profiled in the Plant Breeding and CRISPR Plants Market include Bayer CropScience, Tropic Biosciences, Corteva Agriscience, Pairwise, Syngenta Group, Inari Agriculture, BASF Agricultural Solutions, Benson Hill, KWS SAAT SE & Co. KGaA, Enko Chem, Limagrain, DLF Seeds, Rijk Zwaan, Takii & Co., Ltd., and Sakata Seed Corporation.
In February 2025, KWS SAAT SE & Co. KGaA (Germany) introduced new combination varieties that combined the CONVISO SMART system with high Cercospora protection (CR+), solidifying its market position in the sugarbeet seed industry. These varieties were introduced in several European
markets, with further expansion planned.
In January 2025, Syngenta Vegetable Seeds, part of Syngenta Group (Switzerland) signed a global licensing partnership deal with Apricus Seeds (US), that gives Syngenta exclusive access to Apricus' melon, squash, and watermelon germplasm. This partnership enhanced Syngenta's cucurbits portfolio.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.